documents: FDA-2017-D-6752-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2017-D-6752-0001 | FDA | FDA-2017-D-6752 | Information Requests and Discipline Review Letters Under the Generic Drug User Fee Amendments; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2017-12-18T05:00:00Z | 2017 | 12 | 2017-12-18T05:00:00Z | 2018-02-17T04:59:59Z | 2018-02-17T02:02:50Z | 2017-27124 | 0 | 0 | 0900006482d30211 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref